Location: Home
  • search
  • go
  • Relate News
  • 2/12/2017EU: Chinese Biopharma R&D Investment Growth Highest Globally at 27...
  • 2/12/2017Data Snapshot - Hospital Consumption COPD Drugs in Shanghai
  • 2/10/2017Baidu Withdraws from Mobile Healthcare to Focus on AI-enabled Services
  • 2/9/2017Recent Executive Moves
  • 2/9/2017State Council Issues Major Pharma Industry Reform Policy
  • 2/9/2017Listed Chinese Pharma Companies Forecast Higher Earnings in 2016
  • 2/8/2017Deutsche Bank Expects Substantial mAb Market Growth in China
  • 2/8/2017Yangshibang Raises CNY 110M in Fosun-led Series B Financing
  • 2/8/2017China Will Continue To Rise As A Key Base for Global Pharmaceutical Ma...
  • 2/7/2017Sirnaomics Initiates a Clinical Phase IIa Study of Its siRNA Drug Cand...
  • 2/7/2017PwC: Chinese Hospital M&A Review and Outlook H1/2016
  • 2/7/2017Survey: 33% of Chinese Pharma Marketers Will Spend 20%+ on Digital Cha...
  • 2/6/2017Mobile Medical Healthcare Trends in China
  • 2/6/2017NHFPC Issues New Policy for Trial of Medical Consortiums
  • 2/3/2017Recent Executive Moves
  • 2/2/2017FirboGen Posts Positive Chinese Phase III Data for AZ-Partnered Anemia...
  • 2/2/2017Wuxi PharmaTechs CMO Subsidiary Expands Facility in Changzhou
  • 2/2/2017Trump Wants Big Pharma Cut Outsourcing and Prices, Promising Loosened ...
  • 2/2/2017Tough and Turbulent Time Ahead in the Coming Year of Trump Rooster - 2...
  • 2/1/2017Review of Chinese Pharma Deals, R&D and Regulatory Developments in...
  • 1/27/2017China Healthcare Investment Cools But Remains Impressive
  • 1/26/20172016 Compliance Enforcement in the Pharmaceutical Industry
  • 1/25/2017China's Fast Growing Life Sciences Sector Prepared to Compete for Expe...
  • 1/25/2017China to Issue A Major Reform Policy Covering Full Process of Drug Ind...
  • 1/24/2017Are Reforms Focused on Pharma Kickbacks in China, the Last Straw to Pu...
  • 1/23/2017Chinese Antibody Drug Developer Mabworks Raises $39M in Series B Round...
  • 1/23/2017China Reduces Import Duties of 22 APIs to Zero
  • 1/23/2017The State Council Withdraws Three Local Pharma Approval Requirements, ...
  • 1/22/2017Legochem Licenses China Right of Novel Antibiotic to RMX Biopharma
  • 1/22/2017WuXi AppTec Acquires CRO HD Biosciences
  • Page:167/334 Total number of articles:10002: [First][<<] [165] [166] [167] [168] [169] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group